Researchers have developed and validated a tool for assessing how accurate people are at recognizing emotion in elementary school-aged children. The technique facilitates research on understanding emotions of children – and shows that adults are often wrong when assessing the emotions of children.
Patients with dementia who had signs and risk factors of a pulmonary embolism, or a blood clot in the lungs, were much less likely to be tested for pulmonary embolism than patients without dementia who had the same signs and risk factors.
Testing for some inflammatory proteins associated with the nervous and immune systems will help diagnose the earlier onset and progression of Alzheimer’s disease, according to a Rutgers study.
As COVID-19 cases rise in the U.S., Connect Chicago — new initiative between the Chicago Department of Public Health, Rush University Medical Center, and Esperanza Health Centers — is aiming to redouble testing efforts in Chicago communities that need it most.
With California state vaccination rates slowing, and guidelines on mask wearing and social gatherings changing, the UCLA Center for Health Policy Research (CHPR) has released new data from the 2021 California Health Interview Survey (CHIS) that sheds light on Californians’ views on getting the vaccine and following suggested safety protocols.
The NanoSpot.AI test is estimated to be significantly less expensive to manufacture than other SARS-CoV-2 antibody tests and has the potential to be more affordable than currently available tests, making it possible to extend the test to every corner of the world. Clinical studies validating NanoSpot.AI are currently underway.
DHS S&T awarded $199,653 in Phase 1 funding to Farmspace Systems, LLC, a veteran-owned start-up based in Alamo, Tenn., to enhance its COVID Finder technology, a non-thermal detection COVID-19 screening method.
Atlantic Health System is among the first hospitals in the region to be able to rapidly screen for key viral variants, a key advance for public health amid the pandemic.
Curbing the coronavirus pandemic relies heavily on how quickly a potentially exposed individual can be tested and quarantined. However, the current diagnostic techniques vary in reliability and relevance, so an understanding of which test is most appropriate for a given circumstance is necessary to avoid false reports. Researchers evaluated the available diagnostic techniques and determined key steps required for better testing moving forward. They present their findings in the journal APL Bioengineering.
A new global business survey conducted by the College of Health Solutions at Arizona State University (ASU) and the World Economic Forum (WEF), with support from The Rockefeller Foundation, finds that less than 20% of employers report testing their workers for COVID-19, and 35% have permanently reduced their workforce. The survey, which was completed by 1,125 employers from 29 countries with the majority over a period of six weeks, September to October, found that for companies with employees onsite at the workplace, many are taking some steps to reduce the risk of spreading the virus. Nearly three-fourths (74%) of these companies report they require masks for their employees, and nearly 80% make masks and hand sanitizer available.
Throughout the COVID-19 pandemic, Rush University Medical Center has been a leader in the Chicago area in developing, expanding and evolving testing efforts. On Friday, Nov. 13, the Medical Center performed its 100,000th test for COVID-19.
MOSCOW (MIPT) — As countries like Great Britain consider introducing testing regimes for international arrivals to ease travel restrictions, even as the media continue to cite coronavirus infection statistics by the hour, more people start wondering about the limitations of COVID-19 test…
Researchers at University of California San Diego School of Medicine, in collaboration with local partners, have been awarded a $5 million grant from the National Institutes of Health (NIH) to implement a program of widespread testing for COVID-19 in San Ysidro, focused on pregnant women and children.
Rutgers researchers have created a miniature device for measuring trace levels of toxic lead in sediments at the bottom of harbors, rivers and other waterways within minutes – far faster than currently available laboratory-based tests, which take days. The affordable lab-on-a-chip device could also allow municipalities, water companies, universities, K-12 schools, daycares and homeowners to easily and swiftly test their water supplies. The research is published in the IEEE Sensors Journal.
Research from the University of Notre Dame provides insight into how limited testing and gaps in surveillance during the initial phase of the epidemic resulted in so many cases going undetected.
Emergency authorization by the Food and Drug Administration to use a new and inexpensive rapid saliva test for COVID-19 could be a game changer for tracking and slowing the spread of the virus, says Virginia Tech epidemiologist Charlotte Baker. Quoting…
Rutgers scholar Katherine Ognyanova is available to comment on the latest Rutgers-Harvard-Northeastern-Northwestern survey data on waiting times for diagnostic tests across the United States from The COVID-19 Consortium for Understanding the Public’s Policy Preferences Across States. The researchers surveyed 19,058 people…
Timothy Albertson has received a BARDA grant to lead a new clinical trial at UC Davis Health. The trial evaluates the efficacy, safety and tolerability of an antibody cocktail in hospitalized adult patients with COVID-19.
With cases of the coronavirus spiking in many areas nationwide, public health officials caution that funneling COVID-19 hospitalization data to the HHS rather than the Centers for Disease Control and Prevention (CDC) could slow efforts to end the coronavirus pandemic.…
The University of California San Diego today announced the next step in its Return to Learn program, which will guide an incremental repopulation of the campus while offering broad, asymptomatic testing for faculty, staff and students on a recurring basis to detect the presence of SARS-CoV-2, the novel coronavirus that causes COVID-19.
In response to the high demand for one of the fastest-growing jobs in the U.S., FAU has launched a new, online public health certificate course on COVID-19, contact tracing and risk-reduction. The five-week, 15-hour course does not require a college degree and is scheduled from June 29 to Aug. 7. The program is open to the general public for adults age 18 and older with a high school diploma or equivalent and a variety of work experiences and educational backgrounds.
In a new study, Johns Hopkins researchers found that testing people for SARS-CoV-2 — the virus that causes COVID-19 — too early in the course of infection is likely to result in a false negative test, even though they may eventually test positive for the virus.
To address the nationwide shortage of specialized nasal swabs used for COVID-19 diagnoses, Lawrence Livermore National Laboratory engineers formed an ad hoc, rapid response team that tested more than a dozen novel, 3D-printed swab designs from a grassroots coalition of commercial and academic partners. The mechanical tests performed at the Lab provided valuable feedback that improved the designs, enabling them to meet requirements for COVID-19 testing. The Lab’s work on swabs is continuing with funding from the U.S. Department of Energy (DOE) and expanding into other 3D-printed components for COVID-19 test kits.
– Kantaro Biosciences partners with Bio-Techne for manufacturing and global kit distribution
– Scaled kit production to enable clinical laboratories to conduct 10M tests per month is planned to begin in July
A team of researchers at McMaster University has developed a reliable and accurate blood test to track individual fat intake, a tool that could guide public health policy on healthy eating.
Rutgers’ RUCDR Infinite Biologics received an amended emergency use authorization from the FDA late Thursday for the first SARS-CoV-2 coronavirus test that will allow people to collect their own saliva at home and send to a lab for results. The decision follows the FDA’s recent emergency approval to RUCDR Infinite Biologics for the first saliva-based test, which involves health care workers collecting saliva from individuals at testing sites.
A Rutgers engineer has created a mathematical model that accurately estimates the death toll linked to the COVID-19 pandemic in the United States and could be used around the world. The model, detailed in a study published in the journal Mathematics, predicted the death toll would eventually reach about 68,120 in the United States as a result of the SARS-CoV-2 coronavirus that causes COVID-19. That’s based on data available on April 28, and there was high confidence (99 percent) the expected death toll would be between 66,055 and 70,304.
The American College of Occupational and Environmental Medicine has launched a campaign to inform businesses and the public about the importance of returning to work safely and the specific role that occupational medicine physicians can and should play in this process.
When the COVID-19 outbreak became a pandemic, and the scarcity of testing supplies became a crisis, the leaders of UCLA Biodesign saw the experience and background of Gabriel Oland, MD, as the ideal combination to help reinforce one link in the strained supply chain: the nasopharyngeal swabs used to collect patient specimens for testing.
Testing has been a major cause for concern worldwide ever since the pandemic began, but clinicians and researchers with UAB’s Department of Pathology have been working around the clock to make testing available for as many people as possible, making sure accurate results are available in a timely manner.
A clinical trial conducted by a multi-disciplinary team from Beth Israel Deaconess Medical Center has identified four novel prototypes of 3D-printed swabs that can be used for COVID-19 testing.
Answering the growing need for additional testing, and in direct response to shortages encountered in testing kit supply pipelines, the Coriell Institute for Medical Research is now offering services to create viral testing collection tubes containing different media and/or buffer formulations, for use in COVID-19 testing kits. Coriell is also exploring the feasibility of saliva as a means for testing for the new coronavirus.
The FDA has granted emergency use authorization (EUA) to Rutgers’ RUCDR Infinite Biologics and its collaborators for a new collection approach that utilizes saliva as the primary test biomaterial for the SARS-CoV-2 coronavirus, the first such approval granted by the federal agency. The new saliva collection method, which RUCDR developed in partnership with Spectrum Solutions and Accurate Diagnostic Labs (ADL), will allow for broader population screening than the current method of nose and throat swabs.
A new data visualization tool examines how and why COVID-19 impacts regions differently. Using daily updated data, COVIDMinder compares community risks, mediation tools, and outcomes related to COVID-19 by state across the United States, and by county within New York state.
Nuclear bomb tests during the Cold War in the 1950s and 1960s have helped scientists accurately estimate the age of whale sharks, the biggest fish in the seas, according to a Rutgers-led study. It’s the first time the age of this majestic species has been verified. One whale shark was an estimated 50 years old when it died, making it the oldest known of its kind. Another shark was an estimated 35 years old.
The test is another way that Tulane is working to ease the testing crisis and stop the spread of COVID-19, which has hit the New Orleans area especially hard.
Rutgers’ RUCDR Infinite Biologics has launched a test for the SARS-CoV-2 coronavirus and is using its automation experience and infrastructure to test as many as tens of thousands of samples daily. RUCDR has also submitted an emergency use authorization request for a saliva collection method that will allow for broader population screening.
A laboratory at Tulane Medical Center is conducting a new test for COVID-19 that can yield results within four hours.
An expert team of researchers and clinicians have been working together to design, validate, and implement an “end-to-end” clinical pathology laboratory solution that will allow for the testing of approximately several hundred people per day in order to rapidly diagnose and help guide the selection of treatment and monitor disease course.
A Rutgers University population health epidemiologist is available to comment on the importance of understanding the specificity, sensitivity, and the positive and negative predictive values of the accuracy and precision of Coronavirus testing, and how that knowledge may impact our…
New Brunswick, N.J. (Feb. 26, 2020) – Rutgers University–New Brunswick researchers have created a software tool that more efficiently analyzes how asphalt performs, saving transportation agencies time and money. As performance testing for asphalt pavement has evolved, the focus has shifted…
Cognitive processing in people with intellectual disability can now be accurately assessed thanks to UC Davis Health researchers who updated and validated series of tests, part of the NIH Toolbox Cognitive Battery.
Lawrence Livermore National Laboratory engineers and biologists have developed a “brain-on-a-chip” device capable of recording the neural activity of living brain cell cultures in three-dimensions, a significant advancement in the realistic modeling of the human brain outside of the body.
Students’ high school grade point averages are five times stronger than their ACT scores at predicting college graduation, according to a new study published today in Educational Researcher, a peer-reviewed journal of the American Educational Research Association.